Randomized, placebo-controlled, parallel, multi-center, 12-week study to evaluate the efficacy and safety of albuterol HFA versus the active control, Proventil-HFA in adult and adolescent asthmatic patients.
Phase of Trial: Phase III
Latest Information Update: 12 Jul 2013
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Amphastar Pharmaceuticals
- 12 Jul 2013 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 13 Aug 2010 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
- 02 Apr 2008 New trial record.